Skip to main content
. 2021 Jan 4;13(1):e12488. doi: 10.7759/cureus.12488

Table 4. Association of clinical variables with cognitive impairment (n=240).

*significant P-value, ref: reference variable, OHA: oral hypoglycemic agents

Variable Frequency  n Cognitive Impairment present  n (%) Prevalence ratio (95% Confidence Interval) P-value
Co-morbidity Present 153 50 (32.7) 1.29 (0.84-1.98) 0.230
Absent 87 22 (25.3) 1.00 (ref)
Duration of illness < 5 years 113 33 (29.2) 1.05 (0.71- 1.55) 0.800
≥ 5 years 127 39 (30.7) 1.00 (ref)
Treatment with Insulin 23 9 (39.1) 1.35 (0.78- 2.34) 0.315
OHA 217 63 (29.0) 1.00 (ref)  
Probable symptomatic hypoglycemia Present 95 39 (41.1) 1.80 (1.22- 2.65) 0.002*
Absent 145 33 (22.8) 1.00 (ref)
Tobacco users Ever 56 19 (33.9) 1.18 (0.77- 1.81) 0.464
Never 184 53 (28.8) 1.00 (ref)
Alcohol users Ever 54 9 (16.7) 0.49 (0.26- 0.92) 0.015*
Never 186 63 (33.9) 1.00 (ref)
Physical activity Inadequate 181 56 (30.9) 1.14 (0.71- 1.83) 0.578
Adequate 59 16 (27.1) 1.00 (ref)
Blood sugar levels Uncontrolled 131 40 (30.5) 1.04 (0.70- 1.53) 0.843
Under control 109 32 (29.4) 1.00 (ref)
Body mass index Malnourished 174 54 (31.0) 1.06 (0.71- 1.60) 0.570
Normal 66 18 (27.3) 1.00 (ref)